TABLE 2.

Treatment patterns of matched cohorts during 6‐month follow‐up

	DU vs. SEMA matched cohorts		DU vs. EBCise matched cohorts
	DU, N = 3852	SEMA, N = 3852	DU, N = 1879	EBCise, N = 1879
Initial dose fill, %				Only one dose available
Low	77.5	77.5	65.6
High	22.9	22.9	35.4
Final dose fill, %
Low	54.2	62.6**	46.6
High	45.9	37.5**	53.5
Dosing pattern, %
Low dose only	52.1	59.6**	44.8
High dose only	21.7	20.2	33.5
Low dose to high dose	25.4	17.9**	20.8
All others	1.2	2.7**	1.9
Number of index drug fills
Mean (SD)	4.2 (2.1)	3.8 (2.0)**	4.3 (2.2)	3.6 (2.1)**
Patients with ≥2 index drug fills, %	87.6	85.3*	87.9	78.8**
Patients with ≥4 index drug fills, %	56.8	52.3**	57.5	44.8**

Abbreviations: DU, dulaglutide; EBCise, exenatide BCise; SEMA, semaglutide.

^* P <0.05 vs. dulaglutide.

^** P <0.0001 vs. dulaglutide.